Arrhythmia and thyroid dysfunction

详细信息    查看全文

• 作者：S. Marrakchi (1)
  F. Kanoun (1)
  S. Idriss (1)
  I. Kammoun (1)
  S. Kachboura (1)
  
  1. Abderrahmane Mami hospital ; Tunis ; Tunisia
  
• 关键词：Arrhythmia ; Atrial fibrillation ; Ventricular tachycardia ; Thyroid disease ; Hypothyroidism ; Arrhythmie ; Vorhofflimmern ; Ventrikul盲re Tachykardie ; Schilddr眉senerkrankung ; Hypothyreose
• 刊名：Herz
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：40
• 期：2-supp
• 页码：101-109
• 全文大小：413 KB
• 参考文献：1. Sawin, (1994) N Engl J Med 331: pp. 1249 CrossRef
  2. Golf, (1985) Cardiovasc Res 19: pp. 636 CrossRef
  3. Von, (1989) Am J Cardiol 63: pp. 930 CrossRef
  4. Roffi, (2005) Minerva Endocrinol 30: pp. 47
  5. Polikar, (1993) Circulation 87: pp. 1435 CrossRef
  6. Osman, (2002) J Clin Endocrinol Metab 87: pp. 963 CrossRef
  7. Glass CK, Holloway JM (1990) Regulation of gene expression by the thyroid hormone receptor. Biochim Biophys Acta 1032(2鈥?):157鈥?76
  8. Brent, (1994) N Engl J Med 331: pp. 847 CrossRef
  9. Woeber, (1992) N Engl J Med 327: pp. 94 CrossRef
  10. Dillmann, (1990) Am J Med 88: pp. 626 CrossRef
  11. Klein, (1992) J Clin Invest 89: pp. 68 CrossRef
  12. Danzi, (2008) Thyroid 18: pp. 761 CrossRef
  13. Ojamaa, (2000) Endocrinology 141: pp. 2139
  14. Liu, (1993) Cell Mol Biol Res 39: pp. 221
  15. Ojamaa, (1999) Endocrinology 140: pp. 3170
  16. Davis, (2009) Am J Physiol Endocrinol Metab 297: pp. E1238 CrossRef
  17. Bonow RO, Mann DL, Zipes DP, Libby P (2011) Braunwald鈥檚 heart disease: a textbook of cardiovascular medicine. Elsevier Health Sciences, Amsterdam, p聽11033
  18. Sun, (2001) J Mol Cell Cardiol 33: pp. 811 CrossRef
  19. Hagiwara, (1992) J Physiol 448: pp. 53 CrossRef
  20. Hagiwara, (1988) J Physiol 395: pp. 233 CrossRef
  21. Kodama, (1999) Am J Physiol 276: pp. H793
  22. H眉ser, (2000) J Physiol 524: pp. 415 CrossRef
  23. Kiehn, (1998) J Biol Chem 273: pp. 25285 CrossRef
  24. Johnson, (1973) Cardiology 58: pp. 273 CrossRef
  25. Sakaguchi, (1996) Endocrinology 137: pp. 4744
  26. Apkon, (1991) J Gen Physiol 97: pp. 973 CrossRef
  27. Sun, (2000) Am J Physiol Endocrinol Metab 278: pp. E302
  28. Levey, (1990) Am J Med 88: pp. 642 CrossRef
  29. Williams, (1977) J Biol Chem 252: pp. 2787
  30. Morkin, (1983) Prog Cardiovasc Dis 25: pp. 435 CrossRef
  31. Hoit, (1997) Circulation 96: pp. 592 CrossRef
  32. N, (2005) Indian Pacing Electrophysiol J 5: pp. 305
  33. Ojamaa, (2000) Metabolism 49: pp. 275 CrossRef
  34. Farre, (2004) Europace 6: pp. 464 CrossRef
  35. Freedberg, (1970) J Physiol 207: pp. 357 CrossRef
  36. Chen, (2002) J Am Coll Cardiol 39: pp. 366 CrossRef
  37. Rubinstein, (1989) Naunyn Schmiedebergs Arch Pharmacol 340: pp. 705 CrossRef
  38. Ha茂ssaguerre, (1998) N Engl J Med 339: pp. 659 CrossRef
  39. Chen, (2001) Circulation 104: pp. 2849 CrossRef
  40. Komiya, (2002) Clin Endocrinol: pp. 39
  41. Jao, (2004) South Med J 97: pp. 604 CrossRef
  42. Boccalandro, (2003) Lancet 361: pp. 1432 CrossRef
  43. Fisher, (1982) Arch Intern Med 142: pp. 1362 CrossRef
  44. Mu帽oz-Camacho, (2007) Rev Esp Cardiol Engl Ed 60: pp. 449 CrossRef
  45. Wei, (1979) Am J Cardiol 43: pp. 335 CrossRef
  46. Biondi, (1998) J Clin Endocrinol Metab 83: pp. 2643 CrossRef
  47. Gross, (1985) Naunyn Schmiedebergs Arch Pharmacol 329: pp. 427 CrossRef
  48. Jaeger, (1981) Am J Physiol 240: pp. H934
  49. Qu, (2006) J Cardiovasc Electrophysiol 17: pp. 1042 CrossRef
  50. Meo, (1994) Arch Int Physiol Biochim Biophys 102: pp. 153 CrossRef
  51. Buscemi, (2007) J Endocrinol Invest 30: pp. 230 CrossRef
  52. Polikar, (1986) Am J Cardiol 58: pp. 987 CrossRef
  53. Tribulova N, Knezl V, Shainberg A et al (2010) Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol 52(3鈥?):102鈥?12
  54. Surawicz, (1977) Cardiovasc Clin 8: pp. 243
  55. Nademanee, (1982) Circulation 66: pp. 202 CrossRef
  56. Polikar, (1989) J Am Coll Cardiol 14: pp. 999 CrossRef
  57. Di, (1997) Horm Metab Res 29: pp. 225 CrossRef
  58. Schenck, (2006) Am J Med Sci 331: pp. 154 CrossRef
  59. Fredlund, (1983) Acta Med Scand 213: pp. 231 CrossRef
  60. Unal, (2007) Endocr Pract 13: pp. 711 CrossRef
  61. Lee, (1962) Br Heart J 24: pp. 253 CrossRef
  62. Chess-Williams, (1989) Br J Pharmacol 98: pp. 95 CrossRef
  63. Friberg, (2002) Arch Intern Med 162: pp. 1388 CrossRef
  64. Epstein, (2001) N Engl J Med 344: pp. 501 CrossRef
  65. Frost, (2004) Arch Intern Med 164: pp. 1675 CrossRef
  66. Frost, (2004) Arch Intern Med 164: pp. 1993 CrossRef
  67. Frost, (2005) Int J Cardiol 103: pp. 78 CrossRef
  68. Tunbridge, (1977) Clin Endocrinol: pp. 481
  69. Klein, (2007) Circulation 116: pp. 1725 CrossRef
  70. Nakazawa, (2000) Eur Heart J 21: pp. 327 CrossRef
  71. Zhou, (2011) Intern Med Tokyo Jpn 50: pp. 2947 CrossRef
  72. Xiao P, Gao C, Fan J et al (2011) Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties. Regul Pept 169(1鈥?):31鈥?8
  73. Shimizu, (2002) Thyroid 2: pp. 489 CrossRef
  74. Kunii, (2012) Tokai J Exp Clin Med 37: pp. 107
  75. Bagchi, (1990) Arch Intern Med 150: pp. 785 CrossRef
  76. Ozturk, (2012) Endokrynol Pol 63: pp. 286
  77. Sawin, (1995) Clin Geriatr Med 11: pp. 231
  78. Klemperer, (1996) Ann Thorac Surg 61: pp. 1323 CrossRef
  79. Kim, (2014) Am Heart J 167: pp. 123 CrossRef
  80. Petersen, (1988) Stroke 19: pp. 15 CrossRef
  81. Fuster, (2011) J Am Coll Cardiol 57: pp. e101 CrossRef
  82. Nakazawa, (1982) Am J Med 72: pp. 903 CrossRef
  83. Singh, (2008) J Cardiovasc Pharmacol 52: pp. 300 CrossRef
  84. Narayana, (2011) Ther Adv Endocrinol Metab 2: pp. 115 CrossRef
  85. Bogazzi, (2012) J Endocrinol Invest 35: pp. 340
  86. Cohen-Lehman, (2010) Nat Rev Endocrinol 6: pp. 34 CrossRef
  87. Ganz, (1995) N Engl J Med 332: pp. 162 CrossRef
  88. Denes, (1973) Circulation 48: pp. 549 CrossRef
  89. Rosen, (1974) Am J Cardiol 33: pp. 291 CrossRef
  90. Colzani, (2001) Clin Endocrinol: pp. 27
  91. Davison, (1995) J Electrocardiol 28: pp. 161 CrossRef
  92. Dorian, (1997) Can J Cardiol 13: pp. 13A
  93. Erdogan, (2012) Am J Emerg Med 30: pp. 2092 CrossRef
  94. Biondi, (2005) Eur J Endocrinol 152: pp. 1 CrossRef
  95. Chojnowski, (2007) Cardiol J 14: pp. 198
  96. Samuels, (1998) Thyroid 8: pp. 803 CrossRef
  97. Bakiner, (2008) Med Princ Pract 17: pp. 390 CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Urban & Vogel
• ISSN：1615-6692

文摘

Context Arrhythmia is a major cause of morbidity and mortality in Europe and in the United States. The aim of this review article was to assess the results of the prospective studies that evaluated the risk of arrhythmia in patients with overt and subclinical thyroid disease and discuss the management of this arrhythmia. Evidence acquisition A literature search was carried out for reports published with the following terms: thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinase, atrial flutter, supraventricular arrhythmia, ventricular arrhythmia, ventricular tachycardia, ventricular fibrillation, torsade de pointes, amiodarone and atrial fibrillation. The investigation was restricted to reports published in English. Evidence analysis The outcome of this analysis suggests that patients with untreated overt clinical or subclinical thyroid dysfunction are at increased risk of arrhythmia. Hyperthyroidism increased atrial arrhythmia; however, hypothyroidism increased ventricular arrhythmia. Conclusion The early recognition and effective treatment of thyroid dysfunction in patients with arrhythmia is mandatory because the long-term prognosis of arrhythmia may be improved with the appropriate treatment of thyroid dysfunction.